{"id":"W4411131729","doi":"10.1017/s109285292510031x","title":"Glucagon-like Peptide-1 receptor agonists for the prevention and treatment of Parkinson’s disease","year":2025,"lang":"en","type":"review","venue":"CNS Spectrums","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; University Health Network; Brain and Cognition Discovery Foundation; Queen's University","funders":"Department of Psychiatry, University of Toronto; Health Resources and Services Administration; Substance Abuse and Mental Health Services Administration; Allergan; National Institutes of Health; Bausch Health; National Natural Science Foundation of China; University of Cambridge; Canadian Institutes of Health Research; Sunovion; Eisai; Purdue University; H. Lundbeck A/S; Patient-Centered Outcomes Research Institute; University of Toronto; Biogen; Novo Nordisk; Sanofi; National Institute of Mental Health; Pfizer","keywords":"Parkinson's disease; Medicine; Receptor; Glucagon-like peptide-1; Glucagon-like peptide 1 receptor; Glucagon; Pharmacology; Disease; Agonist; Endocrinology; Internal medicine; Diabetes mellitus; Insulin; Type 2 diabetes","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004635535,0.0007997474,0.001250036,0.002165835,0.0002131821,0.0006817608,0.0006819788,0.0007767262,0.004754069],"category_scores_gemma":[0.0005830055,0.0001803674,0.0007055259,0.001605998,0.0002319897,0.0006410836,0.0005111963,0.001545983,0.001553862],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003766194,"about_ca_system_score_gemma":0.0008038936,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009084932,"about_ca_topic_score_gemma":0.002120736,"domain_scores_codex":[0.9998368,0.00003218007,0.00002619992,0.00002372,0.00006495168,0.00001613556],"domain_scores_gemma":[0.9998,0.00009210535,0.00003666116,0.000005870229,0.00004770686,0.00001767625],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001025553,0.00007935009,0.00008007119,0.03974158,0.000191588,0.0001218207,0.00005784233,0.0003132562,0.00137541,0.002008712,0.02427502,0.9316528],"study_design_scores_gemma":[0.00005248828,0.0001532784,0.000920892,0.01422829,0.000430914,0.0007583923,0.00006122526,0.00009308851,0.0003775617,0.001467007,0.9814384,0.00001850099],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0000897739,0.998965,0.00005122969,0.0001162595,0.0001189769,0.000006095038,0.00001886482,0.00000624016,0.0006274973],"genre_scores_gemma":[0.0005867316,0.9987655,0.00009778355,0.0001237271,0.00005918544,0.000006253747,0.00002734465,9.274229e-7,0.0003325911],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004754069,"threshold_uncertainty_score":0.01590395,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03388562398677773,"score_gpt":0.3256993208346544,"score_spread":0.2918136968478766,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}